We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTOR
2726
Citius Oncology
CTOR
$49.9M
| $74K | ﹤0.01% |
73,992
-52,892
| -42% | -$75.9K |
|
2727
VinFast Auto
VFS
$7.02B
| $73.9K | ﹤0.01% |
+22,140
| New | +$73.9K |
|
2728
Cartesian Therapeutics
RNAC
$218M
| $73.8K | ﹤0.01% |
10,238
-16,021
| -61% | -$130K |
|
|
GGRP
2729
Glimpse Group
GGRP
$19.5M
| $73.7K | ﹤0.01% |
79,552
+55,652
| +233% | +$70.7K |
|
|
SQNS
2730
Sequans Communications SA
SQNS
$37.4M
| $73.4K | ﹤0.01% |
+16,354
| New | +$110K |
|
|
TRUE
2731
DELISTED
TrueCar
TRUE
| $73.4K | ﹤0.01% |
32,458
-27,950
| -46% | -$59.9K |
|
2732
Commercial Vehicle Group
CVGI
$147M
| $73.3K | ﹤0.01% |
50,894
-4,973
| -9% | -$7.91K |
|
2733
Pixelworks
PXLW
$37.2M
| $73.2K | ﹤0.01% |
+11,509
| New | +$88.2K |
|
|
WIMI
2734
WiMi Hologram Cloud
WIMI
$22.1M
| $72.4K | ﹤0.01% |
+30,569
| New | +$104K |
|
2735
Clarus
CLAR
$125M
| $71.7K | ﹤0.01% |
21,405
+11,206
| +110% | +$38.1K |
|
2736
FuboTV Inc
FUBO
$260M
| $71.7K | ﹤0.01% |
2,369
-1,023
| -30% | -$40.8K |
|
|
ASG
2737
Liberty All-Star Growth Fund
ASG
$321M
| $71.5K | ﹤0.01% |
+13,498
| New | +$73.1K |
|
2738
iBio
IBIO
$67.6M
| $71.4K | ﹤0.01% |
+37,014
| New | +$50.5K |
|
|
SLN
2739
Silence Therapeutics
SLN
$546M
| $71.2K | ﹤0.01% |
+11,718
| New | +$75K |
|
|
AMBR
2740
Amber International Holding Ltd
AMBR
$132M
| $71.2K | ﹤0.01% |
+41,135
| New | +$81.2K |
|
2741
Elutia
ELUT
$38.9M
| $71K | ﹤0.01% |
+102,504
| New | +$77.8K |
|
2742
Biote Corp
BTMD
$61.9M
| $71K | ﹤0.01% |
27,299
+579
| +2% | +$1.58K |
|
2743
Lineage Cell Therapeutics
LCTX
$264M
| $70.6K | ﹤0.01% |
+42,281
| New | +$73.2K |
|
|
PCF
2744
High Income Securities Fund
PCF
$98.8M
| $70.6K | ﹤0.01% |
+11,477
| New | +$71.3K |
|
2745
Tronox
TROX
$967M
| $70.5K | ﹤0.01% |
16,899
-48,932
| -74% | -$186K |
|
|
FURY
2746
Fury Gold Mines
FURY
$101M
| $70.1K | ﹤0.01% |
118,757
+85,437
| +256% | +$52.6K |
|
2747
Caesarstone
CSTE
$69.5M
| $69.6K | ﹤0.01% |
37,418
+1,668
| +5% | +$2.35K |
|
|
FLNA
2748
Filana Therapeutics
FLNA
$42M
| $69.2K | ﹤0.01% |
34,928
-53,635
| -61% | -$172K |
|
|
ONCY
2749
Oncolytics Biotech
ONCY
$89.7M
| $68.8K | ﹤0.01% |
+78,661
| New | +$85K |
|
|
BTM
2750
DELISTED
Bitcoin Depot
BTM
| $68.5K | ﹤0.01% |
7,590
-5,185
| -41% | -$79.5K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.